Melissa Rewolinski

Statistics

Publications

Citations

H-Index

Active since

2010

Affiliations

Intercept Pharmaceuticals (United States)(Current)

PRA Health Sciences

Melissa Rewolinski is an author at Intercept Pharmaceuticals (United States) specializing in pharmacokinetic parameters, 5-lipoxygenase inhibition, and clinical pharmacology.

Publications per year

2010–2012

Publications

Pharmacodynamics and Pharmacokinetics of AM103, a Novel Inhibitor of 5-Lipoxygenase-Activating Protein (FLAP)

Gretchen Bain, Christopher D. King, Melissa Rewolinski et al. · Clinical Pharmacology & Therapeutics · 2010 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacodynamics, pharmacokinetics and safety of <scp>GSK</scp>2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor

Gretchen Bain, Christopher D. King, Kevin M. Schaab et al. · British Journal of Clinical Pharmacology · 2012 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

1–2 of 2